Levetiracetam Intrapharm Laboratories

Levetiracetam, the active ingredient in Levetiracetam Intrapharm Laboratories, is an anticonvulsant presented as an intravenous solution for injection use. It is employed in the management of partial‑onset, generalized tonic‑clonic and myoclonic seizures in patients requiring parenteral therapy.

GNH USA supplies Levetiracetam Intrapharm Laboratories as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and procurement teams worldwide, with consistent quality and regulatory compliance.

Levetiracetam is an antiepileptic medication used to control seizure activity in various epilepsy syndromes.

- Partial‑onset seizures: reduces the frequency and severity of focal seizures. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes across both hemispheres. - Myoclonic seizures: decreases the occurrence of sudden, brief muscle jerks.

Levetiracetam may cause a range of adverse reactions, some of which are more frequently observed while others are rare but serious.

Common Side Effects: - Dizziness: mild vertigo or light‑headedness. - Fatigue: feeling unusually tired. - Headache: mild to moderate pain. - Nausea: upset stomach. - Irritability: increased agitation or mood swings. - Insomnia: difficulty falling or staying asleep.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or breathing difficulty. - Mood changes: depression, anxiety, or suicidal thoughts. - Blood disorders: thrombocytopenia, neutropenia, or anemia. - Multiorgan failure: extremely rare systemic involvement. - Stevens‑Johnson syndrome: severe skin reaction. - Hepatic dysfunction: elevated liver enzymes or hepatitis.

Before initiating therapy, clinicians should consider patient‑specific factors and monitor for potential complications.

- Renal impairment: adjust therapy as needed. - Hepatic dysfunction: monitor liver function tests. - Concomitant CNS depressants: may increase sedation. - Pregnancy: risk unknown, use only if benefit outweighs risk. - Elderly: start low, monitor for confusion. - Store at ambient temperature: keep in original container, protect from moisture and light.

Levetiracetam can interact with other medicines, altering its effectiveness or increasing adverse effects.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels. - Phenobarbital: may decrease levetiracetam efficacy. - Phenytoin: may lower levetiracetam concentrations.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., benzodiazepines): increased sedation risk. - Alcohol: may enhance dizziness and drowsiness. - Antihypertensives: possible additive hypotensive effect.